Uherskohradistska nemocnice a.s.
Uherske Hradiste, Czechia
Hospital in Uherské Hradiště
Jana Evangelisty Purkyně 365, 686 68 Uherské Hradiště
About Uherskohradistska nemocnice a.s.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Janssen Research & Development, LLC
1
Molnlycke Health Care AB
1
PregLem SA
1
Clinical Trials at Uherskohradistska nemocnice a.s.
During the past decade, Uherskohradistska nemocnice a.s. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers
2009-12-01
2013-10-01
Completed
201
Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)
2010-10-01
2013-11-01
Completed
109
Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Term Setting
2015-12-01
2022-12-01
Unknown status
1,500
Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)
2018-06-07
2020-08-20
Completed
270
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
2019-01-25
2027-02-19
Active, not recruiting
765
TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE
2020-07-29
2022-02-07
Completed
460
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Uherskohradistska nemocnice a.s.
According to Clinical.Site data, the most researched conditions in "Uherskohradistska nemocnice a.s." are
"Rheumatoid Arthritis" (2 trials), "Ankylosing Spondylitis" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Mixed Leg Ulcers" (1 trials) and "Uterine Fibroids" (1 trials). Many other conditions were trialed in "Uherskohradistska nemocnice a.s." in a lesser frequency.
Clinical Trials Intervention Types at Uherskohradistska nemocnice a.s.
Most popular intervention types in "Uherskohradistska nemocnice a.s." are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Tofacitinib" (2 trials), "Abiraterone Acetate" (1 trials), "Mepilex Ag" (1 trials), "Mepilex without Ag" (1 trials) and "New Formulation of Niraparib and Abiraterone Acetate (AA)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Uherskohradistska nemocnice a.s.
The vast majority of trials in "Uherskohradistska nemocnice a.s." are
4 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Uherskohradistska nemocnice a.s.
Currently, there are NaN active trials in "Uherskohradistska nemocnice a.s.".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Uherskohradistska nemocnice a.s.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Uherskohradistska nemocnice a.s., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".